chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Weird smell of burning plastic in his nostril that goes all the way down his nostril; Right away he felt like his arm was dislocated but that resolved in two days.; Weird smell in nostrils; Felt like arm dislocated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administration date 28Apr2021 (Lot number: EW0169) at the age of 29 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BURNING SENSATION (non-serious), outcome "unknown", described as "Weird smell of burning plastic in his nostril that goes all the way down his nostril"; LIMB DISCOMFORT (non-serious), outcome "recovered", described as "Right away he felt like his arm was dislocated but that resolved in two days."; PAROSMIA (non-serious), outcome "unknown", described as "Weird smell in nostrils"; JOINT DISLOCATION (non-serious), outcome "recovered", described as "Felt like arm dislocated".  Additional Information: "Are there different types of vaccines?  She said there are different types of Pfizers? Do you know what is in the vaccine?" Response stated to caller was there are multiple Covid 19 vaccines however Pfizer only makes one Covid 19 vaccine. Pfizer makes other vaccines for different diseases but there is only one Pfizer Covid 19 vaccine.  Gave caller website address and steps on how to access the Fact Sheet for Recipients which includes the ingredient list. He reports a weird smell of burning plastic in his nostril that goes all the way down his nostril.  Right away he felt like his arm was dislocated but that resolved in two days.  He's heard of other people getting really sick and is debating if he should get the second shot or telling others not to get the vaccine.  "Am I going to have any other issues after the second dose? This is crazy like some kind of experiment.  Is it a normal side effect? Will it go away? I've heard of other people getting the shot and still getting Covid 19.  Can you give someone else Covid 19 from the vaccine? Can you get covid 19 from the vaccine? Do you know what is in the vaccine? Stated we would not be able to predict what kind of reaction someone would have to any doses of the vaccine.  I've heard of other people getting the shot and still getting Covid 19. He's heard of other people getting really sick and is debating if he should get the second shot or of telling others not to get the vaccine. "This is crazy like some kind of experiment." Caller states he should have researched the vaccine more. Consumer asked can you give someone else Covid 19 from the vaccine? Can you get covid 19 from the vaccine? stated the vaccine does not contain the Sars-CoV-2 virus that causes Covid 19 so you can't give Covid 19 to someone else. Per the attached document, stated you can not get Covid 19 from the vaccine.  No follow-up attempts are possible. No further information is expected.
No adverse effects reported; nurse reporting that MMR II was administered too son after VARIVAX; This spontaneous report was received from a registered nurse and refers to a 14 month old patient. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs was not provided.     On 28-AUG-2018, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) one dose, lot # R011805, expiration date 23-APR-2020 (route and anatomical location were not provided) for prophylaxis. On 06-SEP-2018, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) one dose, lot # N024698, expiration date 08-SEP-2019 (route and anatomical location were not provided) for prophylaxis. No adverse effects were reported.
Patient was in for 2nd dose of Monovalent Covid vaccine but instead received the Bivalent vaccine.
I started to experience symptoms I would associate with ADHD. Interrupting people, memory, maintaining focus/attention and task initiation. I have experienced this before, but I feel it was a bit more pronounced after receiving the vaccine. I was not seeking treatment prior to receiving my second dose, but this caused a disturbance to where I started seeking professional help. I was diagnosed with ADHD. I have been put on Strattera to help with the symptoms. It is possible that my anxiety has become a bit more severe since receiving my vaccine.
The same day I received the vaccine at my workplace I had very strong and sharp pain in my left side and center chest. I recently (3 months now) have been exercising and I have been having the same sharp chest pain very often now, it seems to become stronger and my epileptic siezures have been coming back.
shingles; This spontaneous report has been received from a layer regarding a case in litigation, concerning a patient of unspecified age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. In 2009, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, lot #, expiration date, dosage, anatomical location and rote of administration ere not reported), as prescribed and/or administered by a pharmacist at a pharmacy for the long-term prevention of shingles and zoster-related conditions. Subsequent to vaccination, the patient was treated by a physician for shingles (herpes zoster). As a direct and proximate result of zoster vaccine live (ZOSTAVAX) use, he patient had and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome for herpes zoster was not provided. The lawyer considered herpes zoster to be related to zoster vaccine live (ZOSTAVAX).
case was admitted on 2/23 to hospital and tested positive on 3/1 and is still in hospital in ICU.
patient developed rash on left arm close to vaccine injection site 8 days after vaccination. patient rash is improving
Pregnancy; Earlier dose on 18Nov2019, second dose on 28Apr2023; Initial Report Received on 02-May-2023  A pharmacist reported that a 43-year-old pregnant female patient (race and ethnicity unknown) received a dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization.   Medical history, allergies, and concomitant medications at the time of vaccination were unknown.  On 18-Nov-2019, the patient received the first dose of HEPLISAV-B vaccine (Lot #, expiration date, NDC#, route of administration, and site of injection not reported).  On an unknown date, the patient became pregnant.   On 28-Apr-2023, the pregnant patient received the second dose of HEPLISAV-B vaccine (Lot # 941583, expiration date 28-Jan-2025, and NDC # 43528-003-05) intramuscularly in the left arm. The number of weeks gestation and the patient's last menstrual period were unknown. The patient did not report any additional side effects.   No additional information was provided.  Company Comment:  The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
No additional AE reported. No PQC; PNEUMOVAX 23 was administered to one patient during an ongoing temperature excursion; 49-year-old patient received PNEUMOVAX 23; This spontaneous report was received from a physician and refers to a 49-year-old female patient.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 14-MAR-2023, the patient was vaccinated an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe, 0.5 milliliter once, lot #W007035, expiration date: 20-OCT-2023 (strength, anatomical location, and route of administration were not provided) as prophylaxis (product storage error, product administered to patient of inappropriate age). The reporter informed that the vaccine underwent a temperature excursion of 60 Fahrenheit degrees for 24 hours previous the administration. No adverse event was reported.
Fever; Chills; Muscle and joint pain; Muscle and joint pain; Headache; Dizziness; This is a spontaneous report from a non-contactable healthcare professional (patient). A non-pregnant 32-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9261), via an unspecified route of administration in right arm, on 20Jan2021 at 08:30, at a single dose, for COVID-19 immunization. The patient's medical history included endometriosis, anxiety, and depression. The patient was taking unspecified concomitant medications. The patient previously took the first dose of BNT162B2 on 30Dec2020 at 01:30 PM for COVID-19 immunization (in left arm). The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. On 20Jan2021 at 10:00 PM (22:00), the patient experienced fever, chills, muscle and joint pain, headache, and dizziness. The events were considered non-serious. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The patient was recovering from the events.  No follow-up attempts are possible. No further information is expected.
Initial report was received 23 April 2010 from a consumer (the reporter's status as a health care professional could not be confirmed). The reporter stated that they had a two month old patient, and the patient's mother (age not reported) may have experienced a seizure an unspecified amount of time after she had received a pertussis vaccine (manufacturer and lot number not reported) when she was a child. Outcome was not reported. No adverse event was reported for the two month old patient. The reporter declined to provide any additional information. Documents held by sender: None.
Shoulder pain & sore arm. Followed up with client & advised medical care if need be. 3 days later all symptoms disappeared she is doing fine.
Abdominal pain; Weakness; Vomiting through the night; Tiredness; This spontaneous case was reported by an other health care professional and describes the occurrence of ABDOMINAL PAIN (Abdominal pain), ASTHENIA (Weakness), VOMITING (Vomiting through the night) and FATIGUE (Tiredness) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypercholesterolemia. Concomitant products included ALIROCUMAB (PRALUENT) for Cholesterol, DIMENHYDRINATE (DRAMAMINE), EZETIMIBE (ZETIA) and LEVOTHYROXINE for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN (Abdominal pain), ASTHENIA (Weakness), VOMITING (Vomiting through the night) and FATIGUE (Tiredness). At the time of the report, ABDOMINAL PAIN (Abdominal pain), ASTHENIA (Weakness), VOMITING (Vomiting through the night) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Non significant follow up appended.
The patient developed a rash on the upper part of her left arm 6 days after the injection. The area was large, red, and warm to the touch. The patient went to the doctor for them to determine if it was an allergic reaction and if the patient should receive the 2nd dose in the future. Patient did not complain of a fever or shortness of breath.
Approximately 10:40 patient got 3 shots and oral Rotavirus. 1 minute later patient with flushed of legs bilaterally from toes to upper thigh. Diaper area and trunk and arms clear. Face flushed with incessant crying. Tried to calm and feed without success. Patient pulling hair. Given 6.25mgoral Diphenhydramine at 11:03 AM. Patient's skin flush improved within 3 minutes and resolved at 11:14 AM. Residual papules on legs. Photos taken on fathers cell phone. Patient arousable when discharged home. Mother to call later today. Referred to allergist.
Ears clogged a few hours after shot. Poped and reclogged a few times. Ringing in ears started ant approx. 7-9pm. Ears have been ringing ever since.
Redness, swelling, itching at site of injection.  Resolved over next week without treatment.
knot at injection site for about 6 days  severe itching at injection site for about 6 days redness, soreness, and heat at injection site for about a week
Internal swollen arm, the whole arm, pain in the whole arm from the shoulder down to the hand, when cold hurts more either if its outside of inside a place, the pain is feels like muscle spasms, arm feels heavy like its going to fall, can't use it. Pain increases as the days go by.
Pt complained that she had a red round ring around the injection site.  The injection site felt hard, warm and little swollen.
This spontaneous report as received from a physician refers to a patient of unknown demographics. The pertinent medical history was not reported. On 16-FEB-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck). No adverse event was reported. No product quality complaint was involved. Additional information has been requested.
Patient did not have any adverse events from the first shot in the series. The following morning after the second dose, she experienced the symptoms we discussed at the time of the shot aches, fever, malaise, and overall not well, described like having the flu. The next day she experience terrible headaches that were on the right side of her head. These pains came in bursts and would switch locations, top of head, side of head and then behind her right eye.
15 April 99: dose #1-several hours later patient had sore mouth, sore throat, sloughing of "skin in mouth".  29 April 99: dose #2-several hours later had sensation of "throat closing" and sores developing in mouth Per follow-up: Continuous symptoms in the mouth. SM has to drink sterioids on a daily basis and rinse mouth 6 x a day for 10-15 minutes. Need always to be close to a Dermatology since I break out a lot. SM took 3 shots only. All 3 times had to go to emergency room.
Vaccinee rec'd a series of 3 vax (deltoid) according to 0, 1, 6 mos schedule; @ 4+ months p/the third dose Antibody level was zero;
inconsolable crying w/high pitched scream for 4-5 hrs beginning 30 minutes p/inject;
ADMINISTRATION OF VACCINE WHICH REMAINED PUNCTURED IN THE FRIDGE FOR LONGER THAN 6 HOURS; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811, expiry: 20-MAR-2022) dose was not reported, administered on 03-NOV-2021 10:32 for prophylactic vaccination. No concomitant medications were reported. On 03-NOV-2021, the patient experienced administration of vaccine which remained punctured in the fridge for longer than 6 hours. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of vaccine which remained punctured in the fridge for longer than 6 hours was not reported. This report was non-serious.
Patient is having arm pain and swelling at injections site. he is experiencing shooting and burning  sensations from injection to the elbow  recommended tylenol, cold pack and talk in primary md
Itching; Injection spot red; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and INJECTION SITE ERYTHEMA (Injection spot red) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching) and INJECTION SITE ERYTHEMA (Injection spot red). At the time of the report, PRURITUS (Itching) and INJECTION SITE ERYTHEMA (Injection spot red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided  No treatment medications provided
THIS IS 2ND DOSE FOR PATIENT. PATIENT DIDNT HAVE ANY REACTION AFTER 1ST DOSE. REPORTED SWOLLEN ARM AND REDNESS ON RIGHT HAND-STARTED AFTER 1 TO 2 DAYS AFTER VACCINATION. SWELLING IS GOING DOWN LITTLE BY LITTLE BUT REDNESS IS THERE.
On 6/3/21 I woke at about 3am and experienced severe chest pain. It was stabling and pressure. I couldn?t move, I was afraid to move. I thought I was dying. I was eventually able to move my hand to my heart and just prayed. Next thing I knew I woke up next morning. Since then my heart aches. Like a clamp at times. I had another event like that recently but not quite as bad. I have called my doctor for an appointment.
delayed reaction arm has red bump; delayed reaction arm itching; delayed reaction arm sore; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (delayed reaction arm has red bump), VACCINATION SITE PRURITUS (delayed reaction arm itching) and MYALGIA (delayed reaction arm sore) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20Q) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (delayed reaction arm has red bump), VACCINATION SITE PRURITUS (delayed reaction arm itching) and MYALGIA (delayed reaction arm sore). At the time of the report, RASH ERYTHEMATOUS (delayed reaction arm has red bump), VACCINATION SITE PRURITUS (delayed reaction arm itching) and MYALGIA (delayed reaction arm sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Breakthrough case after Covid vaccination. Dose #1 4/8/2021. C/O fever, runny nose, SOA, cough/ onset 9/14/2021
Painful, swollen, stiff joints on fingers, wrists, toes, with limited range of motion. Symptoms began the day after the first dose of the Pfizer COVID vaccine and worsened after the second dose. Over three months since then, symptoms have deteriorated in terms of pain, stiffness, and range of motion.
This spontaneous report was received from a 53 year old female patient who is also a nurse reporting about herself. On 29-OCT-2012, the patient was vaccinated subcutaneously with dose 1 of live ZOSTAVAX(lot#, dose not reported). On 05-NOV-2012, the patient was administered dose 2 live ZOSTAVAX (lot#, dose not reported). Concomitant therapies included PRAVACHOL, XANAX and AMBIEN. On an unknown date in 2012, the patient experienced shingles that ripped the skin off the side of her butt. Those went away at some point in January 2013 but now there are other spots where there are shingles. The location and onset date of these "other spots" were not specified. Since an unknown date, the patient had a cough. Patient received treatment with gabapentin and acyclovir. Patient sought medical attention(she was treated by her physician). No laboratory diagnostics studies were performed. The present patient status was not recovered. VZVIP Packet was faxed. The causality for the event shingles that ripped the skin off the side of her butt with live ZOSTAVAX was unknown. Additional information has been requested.
Admitted for COVID pneumonia. Fully vaccinated. Treated with O2, steroids, redesivir, lovenox, zinc. Condition improved and discharged home with 2L O2.
Tdap given insted of Dtap, clinic R.N. called the CDC hot line and was told that the Tdap as the fourth dose would be sufficient coverage, the fifth dose does need to be Dtap.
Tinnitus (ringing in both ears), treatment: none,  This started 45 minutes after of receiving my second Moderna shot. As of today I still have Tinnitus.
Body ache; Fever; Headache; This is a spontaneous report received from a non-contactable consumer, the patient. A 32-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 32-years-old), as a single dose for COVID-19 immunisation. The patient had no any medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any concomitant medications within two weeks of vaccine. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. On an unknown date in Mar2021, the patient experienced fever, headache and body pain. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fever, headache and general body pain was resolving.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Swelling arm around injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the arm on 09Jun2021 at 10:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history and other medication received within two weeks of vaccination was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Jun2021, the patient experienced swelling arm around injection site. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event swelling arm around injection site was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.